Price of generic version of Apremilast
Generic versionApremilast (Apremilast) is a generic drug with basically the same ingredients as the original drug, mainly including the Indian version and the Lao version. These generic drugs are usually produced by pharmaceutical companies in India or Laos and are available on the international market.
Compared to the original drug, the price of the generic version of Apremilast (Apremilast) is usually more affordable. According to market research, the price of the imitation version of Apremilast (Apremilast) is about two to three hundred yuan per box. Compared with the more than 10,000 yuan of the original drug, this price reduces the financial burden on patients and enables more patients to obtain the treatment they need.

Generic versionThe price of Apremilast (Apremilast) is lower mainly because its production cost is lower than that of the original drug. Pharmaceutical companies usually do not need to invest in the research and development of new drugs in the production of generic drugs, but copy and produce them based on the formula of the original drug. In addition, the drug regulatory agencies in some countries have relatively simplified the approval process for generic drugs, further reducing production costs.
However, although the generic version of Apremilast is less expensive, its quality and efficacy are usually guaranteed. Generic drugs need to follow strict quality control standards during the production process and pass approval and supervision by relevant drug regulatory agencies to ensure that they meet the quality and safety requirements of drugs. Therefore, patients can safely choose the appropriate generic version of Apremilast (apmilast) for treatment.
It should be noted that although the price of the generic version of Apremilast (Apremilast) is lower, patients should still choose formal channels and reputable suppliers when purchasing drugs to ensure the quality and safety of the drugs. In addition, patients should use medications under the guidance of their doctors and have regular follow-up visits to ensure the best therapeutic effect.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)